Inhibition of Human Cytomegalovirus Replication by Benzimidazole Nucleosides Involves Three Distinct Mechanisms

The benzimidazole nucleosides 2-bromo-5,6-dichloro-1-(β-d-ribofuranosyl)benzimidazole (BDCRB) and 2-isopropylamino-5,6-dichloro-1-(β-l-ribofuranosyl)benzimidazole (1263W94, or maribavir) are potent and selective inhibitors of human cytomegalovirus (HCMV) replication. These inhibitors act by two diff...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Evers, David L., Komazin, Gloria, Ptak, Roger G., Shin, Dongjin, Emmer, Brian T., Townsend, Leroy B., Drach, John C.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2004
Aiheet:
Antiviral Agents
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC521925/
https://ncbi.nlm.nih.gov/pubmed/15388453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.10.3918-3927.2004
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia